BONSEYE
Catawba Research Finishes Move!
Check Out Our New Headquarters Catawba Research launched seven years ago. As we set out to build a world-class, full-service contract research organization, our journey quickly led us to many wonderful milestones. These accomplishments include dozens of agency approvals, a site network, and a rapidly-expanding presence around the globe. Now, we’re proud to unveil the…
Catawba Research Moves to Larger U.S. Headquarters
ICON to Acquire PRA Health Sciences, Creating a World Leader in Healthcare Intelligence and Clinical Research
DUBLIN–(BUSINESS WIRE)–ICON plc, (NASDAQ: ICLR), a global provider of outsourced drug and device development and commercialisation services to the pharmaceutical, biotechnology and medical device industries, and government and public health organisations, today announced it has entered into a definitive agreement to acquire PRA Health Sciences, Inc. (NASDAQ: PRAH) in a cash and stock transaction valued at…
Altasciences Acquires WCCT Global
“This acquisition is an integral part of Altasciences’ strategic growth plan to provide a comprehensive, fully integrated early phase drug development solution to address the ever-changing outsourcing challenges of biopharmaceutical companies across the globe. We look forward to working side by side with our new team of clinical experts in California, a team that shares…
St. Cloud Capital Announces Investment In Catawba Research
St. Cloud Capital is pleased to announce an investment in Charlotte, North Carolina-based Catawba Research. St. Cloud has partnered with a financial investment firm focused on control investments in the life sciences and industrial sectors to support Catawba’s next phase of growth. It is an investment out of St. Cloud’s third fund, which has committed capital…
Vyome Therapeutics Achieves Positive Results in Phase 2 Trial of VB-1953
Catawba Research is proud to have served as the CRO for Vyome Therapeutics on their successful Phase 2 Trial of VB-1953 for Moderate to Severe Acne. Needless to say, Catawba Research is excited for our client and honored to be by their side. Vyome Therapeutics is a clinical-stage company developing locally-acting, next generation therapeutics for…
Meet Us at AAD & Experience Catawba Confidence in Your Next Trial!
Catawba Research is heading to Washington, D.C. March 1–3 to attend the American Academy of Dermatology (AAD) 2019 Annual Meeting. During our visit, we will be huddling up with site networks, sponsors, and others to discuss their CRO needs in the year ahead and beyond. With more than 26 studies completed in the last five…
Catawba Research Releases Teaser for Plaque Psoriasis Training Video
Here is a sample of our latest training video on plaque psoriasis with Dr. Zoe Draelos, a leader in clinical and research dermatology. https://vimeo.com/298690316To learn more about our training program or see some our videos, contact us!
Catawba Research Adds Tinea Pedis Video to Training Library
Our latest training video is for tinea pedis. As with all of our training videos, this most recent one is led by a leading expert in the industry and contains extensive technical information specific to the study area / product. After watching our videos, trainees are tested on their retention of the topic.https://vimeo.com/252811270 To learn…
Catawba Research Introduces New Training Video
We are pleased to announce the arrival of our latest training video! We have been hard at work developing and filming comprehensive, indication and product-specific training videos for the individual therapeutic areas we’re conducting trials in. Each video is extensive, with more than 30 minutes of technical information specific to that indication or product, as…